Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981;12(Suppl 1):79S–83S.

Evidence for increase in peripheral blood flow by indoramin in man

A J Coleman
PMCID: PMC1401735

Abstract

1 Indoramin has been reported to reduce blood pressure, antagonise experimental cardiac dysrythmias, and increase peripheral blood flow in patients and normal volunteers.

2 In this study the effect of the drug on heart rate and rhythm, central venous and arterial blood pressures, cardiac output, and leg blood flow was determined in 11 healthy volunteers.

3 Indoramin (5-20 mg) given intravenously resulted in increases in leg blood flow amounting to 260% in the foot and 40% in the calf as estimated by strain gauge plethysmography. No significant change in heart rate or cardiac output was noted, but central venous pressure was diminished (2mm Hg) and arterial pressure decreased (systolic 10mm Hg and diastolic by 6 mm Hg).

4 Haemodynamic responses to isoprenaline (1-4 μg) were not influenced by indoramin but those to noradrenaline (6-20 μg) were diminished suggesting that these responses were due to α-adrenoceptor blockade.

Full text

PDF
79S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alps B. J., Hill M., Johnson E. S., Wilson A. B. Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901). Br J Pharmacol. 1972 Jan;44(1):52–62. doi: 10.1111/j.1476-5381.1972.tb07237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brody M. J., Shaffer R. A. Distribution of vasodilator nerves in the canine hindlimb. Am J Physiol. 1970 Feb;218(2):470–474. doi: 10.1152/ajplegacy.1970.218.2.470. [DOI] [PubMed] [Google Scholar]
  3. Clement D. L. Effect of indoramin on finger blood flow in vasospastic patients. Eur J Clin Pharmacol. 1978 Dec 18;14(5):331–333. doi: 10.1007/BF00611902. [DOI] [PubMed] [Google Scholar]
  4. Collis M. G., Alps B. J. The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations. J Pharm Pharmacol. 1973 Aug;25(8):621–628. doi: 10.1111/j.2042-7158.1973.tb10648.x. [DOI] [PubMed] [Google Scholar]
  5. Coltart D. J., Lockhart J. D., Royds R. B., Turner P. Human pharmacology of indoramin. Br J Pharmacol. 1971 Oct;43(2):467P–468P. [PMC free article] [PubMed] [Google Scholar]
  6. FOX R. H., GOLDSMITH R., KIDD D. J. Cutaneous vasomotor control in the human head, neck and upper chest. J Physiol. 1962 May;161:298–312. doi: 10.1113/jphysiol.1962.sp006887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fares C. M., Milliken J. C. The effect of parenteral indoramin on peripheral blood flow in patients with Raynaud's disease or atherosclerosis associated with intermittent claudication. Curr Med Res Opin. 1974;2(2):57–62. doi: 10.1185/03007997409114245. [DOI] [PubMed] [Google Scholar]
  8. Harrison J., Turner P. Comparison of propranolol and I.C.I. 50,172 on isoprenaline-induced increase in skin temperature in man. Br J Pharmacol. 1969 May;36(1):177P–178P. [PMC free article] [PubMed] [Google Scholar]
  9. Mellander S., Johansson B. Control of resistance, exchange, and capacitance functions in the peripheral circulation. Pharmacol Rev. 1968 Sep;20(3):117–196. [PubMed] [Google Scholar]
  10. Ross G. The regional circulation. Annu Rev Physiol. 1971;33:445–478. doi: 10.1146/annurev.ph.33.030171.002305. [DOI] [PubMed] [Google Scholar]
  11. Warren J. V., Walter C. W., Romano J., Stead E. A. BLOOD FLOW IN THE HAND AND FOREARM AFTER PARAVERTEBRAL BLOCK OF THE SYMPATHETIC GANGLIA. EVIDENCE AGAINST SYMPATHETIC VASODILATOR NERVES IN THE EXTREMITIES OF MAN. J Clin Invest. 1942 Nov;21(6):665–673. doi: 10.1172/JCI101343. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES